-+ 0.00%
-+ 0.00%
-+ 0.00%

Roche: Analyst consensus compiled by the company shows that biosimilar drugs are expected to create a sales gap of 6.2 billion Swiss francs by 2030.

智通财经·09/28/2026 09:09:08
语音播报
Roche: Analyst consensus compiled by the company shows that biosimilar drugs are expected to create a sales gap of 6.2 billion Swiss francs by 2030.